Literature DB >> 20101743

Thiazolidinedione therapy for nonalcoholic steatohepatitis: go, stop, or proceed with caution?

Stephen A Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20101743     DOI： 10.1002/hep.23473

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.

Authors:  Qiang Li; Li Li; Fei Wang; Jian Chen; Yu Zhao; Peijian Wang; Bernd Nilius; Daoyan Liu; Zhiming Zhu
Journal:  Pflugers Arch       Date:  2013-04-21       Impact factor: 3.657

2.  Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease.

Authors:  Weihan Zhao; Lijuan Liu; Yunliang Wang; Tangyou Mao; Junxiang Li
Journal:  Exp Ther Med       Date:  2015-11-09       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.